Thursday, February 02, 2023

GET YER PEANUTS, SALTED PEANUTS

Can boiled peanuts help cure peanut allergies?

Peer-Reviewed Publication

WILEY

Because heat can affect the structure and immunoreactivity of peanuts, researchers recently tested whether a therapy using sequential doses of boiled peanuts followed by roasted peanuts may help children overcome peanut allergies. Their open label, phase 2, single arm clinical trial, which is published in Clinical & Experimental Allergy, generated promising results.

For the trial, 70 children aged 6–18 years old with peanut allergies received 12-hour boiled peanuts for 12 weeks, 2-hour boiled peanuts for 20 weeks, and roasted peanuts for 20 weeks, to a target maintenance dose of 12 roasted peanuts daily.

Fifty-six of the 70 (80%) participants became desensitized to peanuts. Treatment-related adverse events were reported in 43 (61%) participants, 3 of whom withdrew from the trial.

“Oral immunotherapy using boiled followed by roasted peanuts represents a pragmatic approach that appears effective in inducing desensitization and is associated with a favourable safety profile,” the authors wrote.

URL upon publication: https://onlinelibrary.wiley.com/doi/10.1111/cea.14254

 

Additional Information

NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com.

About the Journal
Clinical & Experimental Allergy is the Official Journal of the British Society for Allergy & Clinical Immunology, publishing clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part. Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field.

About Wiley
Wiley is one of the world’s largest publishers and a global leader in scientific research and career-connected education. Founded in 1807, Wiley enables discovery, powers education, and shapes workforces. Through its industry-leading content, digital platforms, and knowledge networks, the company delivers on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on FacebookTwitterLinkedIn and Instagram.

Can algae enhance skin regeneration and wound healing?

Peer-Reviewed Publication

WILEY

A product of a freshwater single-celled green algae called Euglena gracilis may enhance skin regeneration to speed up wound healing, according to new research published in Advanced Materials Interfaces.

Investigators developed a system based on microvesicles that bud from the cell surface of Euglena gracilis and contain β-glucan, a carbohydrate with immunoregulatory activity, regeneration ability, and antioxidant properties.

In laboratory experiments, these microvesicles promoted the proliferation and migration of skin cells, increasing both collagen synthesis and the expression of proliferation-associated proteins. A wound healing test also generated promising results. 

“This technique is expected to be applied to other cells, thereby enabling the design of new types of extracellular vesicles that are applicable for skin treatments and care in the pharmaceutical and cosmetic industries,” the authors wrote.

URL upon publication: https://onlinelibrary.wiley.com/doi/10.1002/admi.202202255

 

Additional Information

NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com.

About the Journal
Advanced Materials Interfaces publishes applied, top-level research on functional interfaces and surfaces and their specific applications, driving forward our understanding of interfacial processes. Considering that interfaces between solids, liquids, and gases play an essential role in virtually all materials and devices, the journal’s scope encourages an interdisciplinary blend of physics, chemistry, materials science, and life sciences

About Wiley
Wiley is one of the world’s largest publishers and a global leader in scientific research and career-connected education. Founded in 1807, Wiley enables discovery, powers education, and shapes workforces. Through its industry-leading content, digital platforms, and knowledge networks, the company delivers on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on FacebookTwitterLinkedIn and Instagram.

SHH! DON'T TELL DESANTIS💩

UNF study finds dual COVID and flu vaccination reduces infection rates

Peer-Reviewed Publication

UNIVERSITY OF NORTH FLORIDA

Jacksonville, Fla. – University of North Florida Brooks College of Health faculty recently published a study showing dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates and can be an effective strategy to reduce the contagious respiratory disease burden during the winter.

The study found individuals with dual vaccination and COVID-19 vaccine only were significantly less likely to report COVID-19 infection when compared with those unvaccinated. There was no significant difference in self-reported COVID-19 symptom severity by vaccination status.

Dr. Zhigang Xie, public health assistant professor, and Dr. Hanadi Hamadi, health administration associate professor, partnered with two University of Florida researchers for the study. Using data from the 2021 National Health Interview Survey, the team conducted descriptive analysis and multivariate logistic regressions to examine the association between dual vaccination status and self-reported COVID-19 infection and severity among 21,387 (weighted 185,251,310) U.S. adults. Of those in the survey, about 22% did not receive either the flu or COVID-19 vaccine, 6.0% received the flu vaccine only, 29.1% received the COVID-19 vaccine only, and 42.5% received both vaccines.

Read the full study in the latest issue of Vaccine journal.

About University of North Florida

The University of North Florida is a nationally ranked university located on a beautiful 1,381-acre campus in Jacksonville surrounded by nature. Serving 17,000 students, UNF features six colleges of distinction with innovative programs in high-demand fields. UNF students receive individualized attention from faculty and gain valuable real-world experience engaging with community partners. A top public university, UNF prepares students to make a difference in Florida and around the globe. Learn more at www.unf.edu.

###

JOURNAL

METHOD OF RESEARCH

ARTICLE TITLE

JOURNAL

DOI

METHOD OF RESEARCH

SUBJECT OF RESEARCH

ARTICLE TITLE

GNOSIS OF AGING

The nose knows: study suggests it may be wise to screen for smell loss to predict frailty and unhealthy aging

Peer-Reviewed Publication

JOHNS HOPKINS MEDICINE

In a study using data from nearly 1,200 older adults, Johns Hopkins Medicine researchers have added to a growing body of evidence that loss of the sense of smell is a predictive marker for an increased risk of frailty as people age. Building on previous research showing that olfactory dysfunction is a common early sign of brain-linked cognitive decline, the new findings suggest the link to frailty is likely not just in the brain but also in the nose itself.

If further studies affirm the findings, the researchers say, screening older adults’ ability to smell various scents could be as important as testing hearing and vision over time.

Results of the study, published Jan. 10 in the Journal of Gerontology, looked at the prevalence of frailty, an age-related syndrome of physiological decline, along with two different ways of assessing the ability to smell: olfactory sensitivity (the ability to detect an odor’s presence) and olfactory identification (the ability to detect and name an odor). Olfactory identification is a central measure of smell function, which has been linked to frailty and relies on higher-order cognitive processing to interpret and classify an odor. This suggests that neurological function may help to explain the relationship between smell and frailty. However, researchers say the ability to merely detect an odor without having to use higher-level neurological processes and the relationship of the ability to detect odors alone with frailty have been understudied.

“We use our sense of smell to identify the threat of a fire or to enjoy the fragrance of flowers on a spring day. But just like vision and hearing, this sense weakens as we age,” says Nicholas Rowan, M.D.,, associate professor of otolaryngology–head and neck surgery and corresponding author of the study. “We found that both impaired olfactory identification and sensitivity functions are associated with frailty, which is interesting because it shows that it’s not just your aging brain at work here, but it may also be something peripheral, like something at the level of your nose that is able to predict our impending frailty and death.” Rowan remarks that although these findings in older adults add to a body of literature that suggests the sense of smell can be a bellwether of frailty and impending mortality, the relationship of these unique sensory losses with unhealthy aging over time is unclear.

What is clear, he notes, is that common consequences of smell loss include a loss of appetite, difficulty monitoring personal hygiene, depression and an inability to detect toxic fumes. In older adults, this may be associated with weight loss, malnutrition, weakness, inadequate personal care and even potential injuries caused by gas leaks or fires.

In the United States, the population of older adults is estimated to double in the next three decades, driving efforts to sort out which older adults are most likely to experience frailty, a strong marker of impending death compared to those without it. The new study used a standard assessment of frailty (called a Physical Frailty Phenotype, or PFP, score) that looks at five markers: weight loss, exhaustion, weakness, slow walking speed and low physical activity.

To examine the relationship between frailty and olfaction, the research team analyzed data from 1,160 older adults enrolled in the National Social Life, Health and Aging Project between 2015 and 2016. The mean age of subjects was 76 and 55.7% were female. Participants were exposed to five scents to measure olfactory identification and six scents to measure sensitivity levels. Results were then matched to a subject’s frailty score.

Researchers concluded that for every one-point increase in both olfactory identification and sensitivity scores, there was a significant and meaningful reduction in frailty status, implying that improvements in smell were associated with improved health status and resilience of older results. Conversely, the worse the sense of smell, the frailer a subject was, suggesting that smell loss can be a measurable biomarker and potential risk factor for frailty in older adults.

As a matter of practical medical care, Rowan says the findings mean that smell tests could become part of routine screenings as a way to identify someone’s risk of unhealthy aging, and a tipoff to whether additional tests of cognition and other conditions are needed.

“We already do tests to assess how well we can see or hear, and it’s just as easy to conduct a simple smell test that takes only minutes, which could potentially be used as a valuable tool to assess the risk of frailty or unhealthy aging,” says Rowan. “For example, if someone flunks a smell test then maybe this patient needs to improve their nutrition or undergo a more detailed neurological or medical workup.”

In an effort to answer this question, Rowan and his colleagues from the Johns Hopkins University Claude D. Pepper Older Americans Independence Center are actively investigating how more detailed smell tests may help researchers and clinicians alike in identifying physiologically vulnerable older adults. Rowan notes that these results are especially important in the setting of the COVID-19 pandemic, which has caused lasting smell loss for millions of individuals. “The really interesting question, though, is what happens to these novel relationships when you seek to treat the smell loss,” he says. 

Other researchers involved in this study include Nimesh Nagururu, Isaac Bernstein, Kristin Voegtline, Sarah Olson and Yuri Agrawal. 

Funding from this study was supported by the Johns Hopkins Biostatistics, Epidemiology and Data Management (BEAD) Core; and the Johns Hopkins University Claude D. Pepper Older Americans Independence Center funded by the National Institute on Aging of the National Institutes of Health. 

No authors report any conflict of interest.

JOURNAL

Does the risk of stroke from common risk factors change as people age?


Peer-Reviewed Publication

AMERICAN ACADEMY OF NEUROLOGY

MINNEAPOLIS – High blood pressure and diabetes are known risk factors for stroke, but now a new study shows that the amount of risk may decrease as people age. The study is published in the January 18, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

“High blood pressure and diabetes are two important risk factors for stroke that can be managed by medication, decreasing a person’s risk,” said study author George Howard, DrPH, of the University of Alabama at Birmingham School of Public Health. “Our findings show that their association with stroke risk may be substantially less at older ages, yet other risk factors do not change with age. These differences in risk factors imply that determining whether a person is at high risk for stroke may differ depending on their age.”

The study involved 28,235 people who had never had a stroke. Of this group, 41% were Black and 59% were white. Participants were followed for an average of 11 years.

At the start of the study, participants were interviewed and given physical exams to assess risk factors. Risk factors included high blood pressure, diabetes, smoking, atrial fibrillation, heart disease and left ventricular hypertrophy which is the thickening of the heart’s left ventricle. Because of the well-known higher stroke risk in Black people, race was also considered as part of the assessed risk factors, Howard added.

Researchers followed up with participants every six months, confirming strokes by reviewing medical records.

During the study, there were 1,405 strokes over 276,074 person-years. Person-years represent both the number of people in the study and the amount of time each person spends in the study.

Participants were divided into three age groups, which were then compared. The age ranges for those groups varied slightly depending on the data being analyzed by researchers. In general, the younger group included participants ages 45-69, the middle group included people in their late 60s to 70s and the older group included people 74 and older.

Researchers found that people with diabetes in the younger age group were approximately twice as likely to have a stroke as people of similar age who did not have diabetes, while people with diabetes in the older age group had an approximately 30% higher risk of having a stroke than people of similar older age who did not have diabetes.

Researchers also found that people with high blood pressure in the younger age group had an 80% higher risk of having stroke than people of similar age without high blood pressure while that risk went down to 50% for people with high blood pressure in the older age group compared to people of similar age without high blood pressure.

In addition, when researchers examined race as a risk factor, they found a higher stroke risk for Black participants in the younger age group compared to white participants in that group. The race difference decreased in the older age group. For stroke risk factors such as smoking, atrial fibrillation and left ventricular hypertrophy, researchers did not find an age-related change in risk.

“It is important to note that our results do not suggest that treatment of high blood pressure and diabetes becomes unimportant in older age,” said Howard. “Such treatments are still very important for a person’s health. But it also may be wise for doctors to focus on managing risk factors such as atrial fibrillation, smoking and left ventricular hypertrophy as people age.”

Howard also noted that even where the impact of risk factors decreases with age, the total number of people with strokes at older ages may still be larger since overall risk of stroke increases with age. For example, in the younger age group for high blood pressure, researchers estimate that about 2.0% of people with normal blood pressure had a stroke, compared to 3.6% of people with high blood pressure. In the older age group, about 6.2% of people with normal blood pressure had a stroke, compared to 9.3% of people with high blood pressure.

A limitation of the research was that participants’ risk factors were assessed only once at the start of the study, and it’s possible they may have changed over time.

The study was supported by the National Institutes of Health, including the National Institute of Neurological Disorders and Stroke and the National Institute on Aging.

Learn more about stroke at BrainandLife.org, home of the American Academy of Neurology’s free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on FacebookTwitter and Instagram.

When posting to social media channels about this research, we encourage you to use the hashtags #Neurology and #AANscience.

The American Academy of Neurology is the world’s largest association of neurologists and neuroscience professionals, with over 38,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, concussion, Parkinson’s disease and epilepsy.

For more information about the American Academy of Neurology, visit AAN.com or find us on FacebookTwitterInstagramLinkedIn and YouTube.